Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer

Clinical Genetics

Saved in:

Bibliographic Details
Main Authors:	Lim, Y.K., Ali, A.B., Sng, J.-H., Iau, P.T.C., Lee, S.C., Wong, J.-E., Putti, T.C.
Other Authors:	SURGERY
Format:	Article
Published:	2012
Subjects:	Asian population BRCA1 BRCA2 Breast/ovarian cancer Genomic rearrangements
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/33160
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer
by: Lim, Y.K., et al.
Published: (2011)

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
by: Kang, P., et al.
Published: (2014)

IDENTIFICATION AND CHARACTERISATION OF BRCA GENOMIC REARRANGEMENT IN SINGAPORE PATIENTS WITH EARLY ONSET OR FAMILIAL BREAST AND/OR OVARIAN CANCER
by: LIM YEW KOON
Published: (2019)

BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer
by: Ali, A.B., et al.
Published: (2012)

Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer
by: Iau, P.T.C., et al.
Published: (2014)

Genetic and epigenetic alterations in the BRCAI gene in Singapore breast and/or ovarian cancer: A population-based study
by: AZHAR BIN ALI
Published: (2010)

Genetic changes resulting in breast and ovarian cancers in BRCA 1/2 negative families in Thailand
by: Malinee Pongsavee
Published: (2023)

The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives
by: Sng, J.-H., et al.
Published: (2014)

The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives
by: Sng, J.-H., et al.
Published: (2014)

A role of BRCA1-associated protein BARD1 in oxidative stress response and signaling and proliferation control
by: Irminger-Finger, I., et al.
Published: (2016)

Functional Analysis of Familial Asp67Glu and Thr1051Ser BRCA1 Mutations in Breast/Ovarian Carcinogenesis
by: Malinee Pongsavee, et al.
Published: (2012)

Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history
by: Kang, P.C.E., et al.
Published: (2014)

Hereditary breast cancer: A brief overview
by: Sng, J.-H.
Published: (2014)

BRCA1 mutations in the family history clinic
by: IAU TSAU CHOONG, PHILIP
Published: (2010)

Laboratory Verification of a BRCA1 and BRCA2 Massively Parallel Sequencing Assay from Wet Bench to Bioinformatics for Germline DNA Analysis
by: Poon, Kok-Siong, et al.
Published: (2021)

The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: A case report
by: Damayanti, Z., et al.
Published: (2011)

The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: A case report
by: Damayanti, Z., et al.
Published: (2011)

Telomere-chromosome integrity in breast cancer
by: ANURADHA POONEPALLI
Published: (2010)

Role of BRCA2 in DNA repair
by: CHANG JAW-SHIN
Published: (2010)

Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
by: Marijon, Hélène, et al.
Published: (2022)

An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia
by: Yuen, Jeanette, et al.
Published: (2021)

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
by: Maxwell C.A., et al.
Published: (2019)

Evaluation of the relative effectiveness of the 2017 updated Manchester scoring system for predicting BRCA1/2 mutations in a Southeast Asian country
by: Chew, Winston, et al.
Published: (2019)

Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients
by: Ngoi, N., et al.
Published: (2014)

BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity
by: Tacconi, E.M.C, et al.
Published: (2020)

Factors affecting breast cancer patients' need for genetic risk information: From information insufficiency to information need
by: Hong, Soo Jung, et al.
Published: (2019)

Multiple duplicated gene rearrangement algorithm for arbitrary target
by: Jakkarin Suksawatchon
Published: (2011)

A step towards the ambition of precision oncology in recurrent ovarian cancer
by: Wijaya, Silvana Talisa, et al.
Published: (2022)

Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians
by: Han, Mi-Ryung, et al.
Published: (2021)

Predictive factors for BRCA1 and BRCA2 genetic testing in an asian clinic-based population
by: Wong E.S.Y., et al.
Published: (2020)

Rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk
by: Liu, J, et al.
Published: (2020)

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
by: Lawrenson, Kate, et al.
Published: (2021)

The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity
by: Colombo, M, et al.
Published: (2020)

Cancer-specific methylation in the BRCA1 promoter in sporadic breast tumours
by: Ali, A.B., et al.
Published: (2011)

Thermally Rearranged Polymeric Membranes for Gas Separation
by: WANG HUAN
Published: (2013)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
by: Lu, Yen-Shen, et al.
Published: (2022)

Ovarian response after laparoscopic ovarian cystectomy for endometriotic cysts in 132 monitored cycles
by: Loh, F.-H., et al.
Published: (2013)

Ovarian Cancer
Published: (2017)

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
by: Puppe, J, et al.
Published: (2020)

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
by: Tan, T.Z., et al.
Published: (2014)